Jupiter Life Line Hospitals Limited — PPTs, 31-07-2026: Investor Presentation
Jupiter Life Line Hospitals (JLHL) posted Q1FY27 results with strong revenue growth but a dip in profits due to expansion costs.
**Business Performance:** Total Income grew 16.4% YoY to Rs 411.0 Cr. However, Profit After Tax (PAT) decreased 14.7% to Rs 37.5 Cr, and EBITDA was up just 1.1% to Rs 79.3 Cr. This was mainly due to a Rs 9.5 Cr operational loss from the new Dombivli hospital during its initial ramp-up, plus higher marketing, depreciation, and finance costs. Operational beds increased to 1,259, and Average Revenue Per Occupied Bed (ARPOB) rose to Rs 73,500.
**Growth Drivers & Strategy:** JLHL is aggressively expanding bed capacity from 1,700 to 2,900, with projects in Pune II (under construction) and plans for Mira-Bhayandar & BKC. Funding strategy relies on internal accruals and current cash of Rs 537.7 Cr, aiming to keep Debt/EBITDA below 3x. Dombivli is adding specialties and boosting patient footfall.
**Management Outlook:** Management confirmed Dombivli's ramp-up loss is as projected, expecting improved patient inflows from insurance tie-ups. Established hospitals continue to ensure a stable financial base.
